The future of cancer treatment and research: What IBM Watson means for our patients

My secret for surviving with mesothelioma! Frequently I get asked what is…On MyBiologica.comHealth is the level of functional or metabolic efficiency of a living being. In humans, it is the general condition of a person’s mind and body, usually meaning to be free from illness, injury or pain.Alternative medicine is any of a wide range of health care practices, products and therapies, using methods of medical diagnosis and treatments which, at least up to the end of the twentieth century, were typically not included in the degree courses of established medical schools teaching medicine. Examples include homeopathy, Ayurveda, chiropractic and acupuncture.On MyBiologica.com all you are looking for about alternative medicine and health.Coming soon section with best cheapset health insurance offers for …

via My Biologica:

The future of cancer treatment and research: What IBM Watson means for our patients

via Cancerwise | Cancer blog from MD Anderson Cancer Center:

At MD Anderson, we’re constantly looking for innovative new

ways to provide the best possible cancer treatment options for our patients as

we work toward our mission of Making Cancer History®. To help with this, we’ve

enlisted a cognitive computing system powered by IBM Watson.

This technology, known as Oncology Expert Advisor™ (OEA),

will soon be used by our doctors and researchers as part of our Moon Shots Program, starting

with our fight against leukemia.

Ultimately, we hope to use the OEA in all of our clinics to help our patients

regardless of their cancer type.

By pulling together and analyzing vast amounts of

information from patient and research databases, the OEA is expected to help our

care teams identify and fine-tune the best possible cancer

treatments for our patients, while also alerting them to problems that arise

during a patient’s care. The OEA is also expected to help our researchers

advance new discoveries in our fight against cancer.

We recently spoke with Courtney DiNardo, M.D., assistant

professor in Leukemia, who’s been testing the OEA before it debuts in our leukemia

clinic. Here’s what she had to say.

What are the benefits

of using the OEA to organize and collect data about

our patients?
The OEA can extract patient information from various data sources and

synthesize all available medical records into a clear, concise and accurate

synopsis. It can analyze clinical information, medical history, as well as

leukemia-related information, such as specific genetic and molecular features,

and look at all available information in the context of published

evidence-based guidelines and available clinical

trials.

The OEA also allows us to look at changes in a patient’s

condition over time, enabling us to learn a wealth of information within

seconds and answer complex medical questions with speed, accuracy and

confidence. This has an enormous potential to help us make the best cancer

treatment decisions for our patients and the best research decisions that can

help us make progress in our fight against cancer.

What does the use of

the OEA mean for the future of personalized medicine?

The OEA enables us to provide better, more personalized care through accurate

and evidence-based treatment recommendations based upon a specific patient’s

characteristics as well as his or her leukemia-specific characteristics.

The OEA also can help doctors identify the best cancer

treatment for a particular patient by identifying both the standard treatment options

and clinical trials for which a patient is eligible.

Additionally, by following a patient over time along with

the physician, the OEA helps minimize potential adverse events and optimize

management of the patient’s care at all times.

How – and how soon – will

the OEA change cancer treatment here at MD Anderson?
The OEA is currently in the testing and evaluation stage in MD Anderson’s Department

of Leukemia. The actual timeline of when this will be available to our

leukemia patients and then expanded to patients with other types of cancer is

not currently known.

We’re hoping that soon, various medical providers, including

physicians, mid-level providers and research teams, will soon be able to use it

to assimilate complex and ever-expanding genomic data and published scientific research.

The OEA then integrates this information with patient data to provide insights

and helps us select the best cancer treatment for each and every patient.

What does the OEA

mean for cancer care beyond MD Anderson?
The OEA has the potential to “democratize” cancer care, meaning that any physician

with Internet access will be able to access the latest scientific knowledge and

MD Anderson’s expertise.

For physicians who aren’t leukemia experts, the OEA can

function as an expert second opinion, allowing them to access the same

knowledge and information we have here. This will enable doctors even in remote

areas to provide the highest standard of care to patients who can’t travel to

Houston for their cancer treatment.

As a doctor, what do

you consider the OEA’s greatest potential?

The ability to integrate patient level data such as additional medical history,

medications, alongside cancer genomics, as well as cancer therapy received and

responses, side

effects, etc., will provide an unparalleled research platform that can be

used to generate questions, explore hypotheses and provide answers to critical

research questions.

For example, the OEA will also enable us to analyze why

certain patients respond to certain cancer treatments and why particular patients

experience certain side effects, using a research platform that is currently not

available. This gives us the potential to really learn from the vast amount of

information we currently have, and use it to advance cancer research and to benefit

each individual patient.

I’m excited about the possibilities for accelerating new

research and providing the most effective treatments and cures for our patients.

Learn about MD Anderson’s Moon Shots Program .

For more info: The future of cancer treatment and research: What IBM Watson means for our patients

Cancerwise | Cancer blog from MD Anderson Cancer Center

The future of cancer treatment and research: What IBM Watson means for our patients

L’articolo The future of cancer treatment and research: What IBM Watson means for our patients sembra essere il primo su My Biologica.

For more info: The future of cancer treatment and research: What IBM Watson means for our patients

My Biologica

The future of cancer treatment and research: What IBM Watson means for our patients

The post The future of cancer treatment and research: What IBM Watson means for our patients appeared first on FX FOREX.

via WordPress http://www.evvi.net/1936/world-news/the-future-of-cancer-treatment-and-research-what-ibm-watson-means-for-our-patients.html



World News, cancer-research, cheapset-health, established, examples, health, injury-or-pain, insurance, leukemia, mybiologica, secret, usually-meaning